Aldose Reductase: a cause and a potential target for the treatment of diabetic complications

被引:0
作者
Sapna Thakur
Sonu Kumar Gupta
Villayat Ali
Priyanka Singh
Malkhey Verma
机构
[1] Central University of Punjab,Department of Biochemistry, School of Basic & Applied Sciences
[2] Banaras Hindu University,School of Biotechnology, Institute of Science
来源
Archives of Pharmacal Research | 2021年 / 44卷
关键词
Aldose reductase; Aldose reductase inhibitors; Diabetic complications; Hyperglycaemic conditions; Sorbitol dehydrogenase;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes mellitus, a disorder of metabolism, results in the elevation of glucose level in the blood. In this hyperglycaemic condition, aldose reductase overexpresses and leads to further complications of diabetes through the polyol pathway. Glucose metabolism-related disorders are the accumulation of sorbitol, overproduction of NADH and fructose, reduction in NAD+, and excessive NADPH usage, leading to diabetic pathogenesis and its complications such as retinopathy, neuropathy, and nephropathy. Accumulation of sorbitol results in the alteration of osmotic pressure and leads to osmotic stress. The overproduction of NADH causes an increase in reactive oxygen species production which leads to oxidative stress. The overproduction of fructose causes cell death and non-alcoholic fatty liver disease. Apart from these disorders, many other complications have also been discussed in the literature. Therefore, the article overviews the aldose reductase as the causative agent and a potential target for the treatment of diabetic complications. So, aldose reductase inhibitors have gained much importance worldwide right now. Several inhibitors, like derivatives of carboxylic acid, spirohydantoin, phenolic derivatives, etc. could prevent diabetic complications are discussed in this article.
引用
收藏
页码:655 / 667
页数:12
相关论文
共 424 条
[1]  
Ahsan H(2015)Diabetic retinopathy-biomolecules and multiple pathophysiologies Diabetes Metab Syndr 9 51-54
[2]  
Akileshwari C(2014)Bioflavonoid ellagic acid inhibits aldose reductase: implications for prevention of diabetic complications J Funct Foods 6 374-383
[3]  
Raghu G(2016)The role and prevalence of polyol pathway and oxidative stress markers as risk factors for diabetic cataract in adult type-I diabetic and diabetic cataract saudi patients J Clin Exp Ophthalmol 7 3-90
[4]  
Muthenna P(2014)Diagnosis and classification of diabetes mellitus Diabetes Care 37 81-5
[5]  
Mueller NH(2017)Exploration of thioxothiazolidinone–sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: a synthetic and computational investigation Bioorg Chem 75 1-363
[6]  
Suryanaryana P(2011)Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE) Chem Biol Interact 191 357-1418
[7]  
Petrash JM(2018)Acid derivatives of pyrazolo [1, 5-a] pyrimidine as waldoes reductase differential inhibitors Cell Chem Biol 25 1414-3985
[8]  
Reddy GB(2016)Diabetic neuropathy and treatment strategy-new challenges and applications Smart Drug Deliv Syst 7 3979-1625
[9]  
Alwadani F(2019)Astaxanthin inhibits aldose reductase activity in Psammomysobesus, a model of type 2 diabetes and diabetic retinopathy Food Sci Nutr 54 1615-52
[10]  
Saif M(2005)The pathobiology of diabetic complications: a unifying mechanism Diabetes 302 46-1380